Previous studies have reported that high CDK7 expression, together with Cyclin H and MAT1, was associated with better prognosis in ER-positive breast cancer patients [21] and worse prognosis in triple negative breast cancer patients [18]. Here, CCNH is linked to triple-negative breast carcinoma.